Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model

被引：34

作者：

Lu, Mengji ^{[1
]}

Yao, Xin ^{[2
]}

Xu, Yang ^{[1
]}

Lorenz, Heike ^{[3
]}

Dahmen, Uta ^{[4
]}

Chi, Haidong ^{[4
]}

Dirsch, Olaf ^{[5
]}

Kemper, Thekla ^{[1
]}

He, Lifang ^{[2
]}

Glebe, Dieter ^{[3
]}

Gerlich, Wolfram H. ^{[3
]}

Wen, Yumei ^{[2
]}

Roggendorf, Michael ^{[1
]}

机构：

[1] Univ Klinikum Essen, Inst Virol, D-45122 Essen, Germany

[2] Fudan Univ, Med Ctr, Dept Mol Virol, Shanghai 200433, Peoples R China

[3] Univ Giessen, Inst Med Virol, Giessen, Germany

[4] Univ Klinikum Essen, Klin Allgemein Viszeral & Transplantat Chirurg, Essen, Germany

[5] Univ Klin Koln, Inst Pathol, Cologne, Germany

来源：

JOURNAL OF VIROLOGY | 2008年 / 82卷 / 05期

关键词：

D O I：

10.1128/JVI.01613-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The essential role of multispecific immune responses for the control of hepatitis B virus (HBV) infection implies the need of multimodal therapeutic strategies for chronic HBV infection, including antiviral chemotherapy and immunomodulation. This hypothesis was tested in the woodchuck model by a combination of lamivudine pretreatment and subsequent immunizations of woodchucks chronically infected with woodchuck hepatitis virus. The immunizations were performed with DNA vaccines or antigen-antibody immune complexes (IC)/DNA vaccines. Immunizations with IC/DNA vaccines led to an anti-woodchuck hepatitis virus surface antibody response and significant reductions of viral load and antigenemia, suggesting that such a strategy may be effective against chronic HBV infection.

引用

页码：2598 / 2603

页数：6

共 46 条

[1] Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy [J].

Boni, C ;

Penna, A ;

Ogg, GS ;

Bertoletti, A ;

Pilli, M ;

Cavallo, C ;

Cavalli, A ;

Urbani, S ;

Boehme, R ;

Panebianco, R ;

Fiaccadori, F ;

Ferrari, C .

HEPATOLOGY, 2001, 33 (04) :963-971

[2] Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B [J].

Boni, C ;

Bertoletti, A ;

Penna, A ;

Cavalli, A ;

Pilli, M ;

Urbani, S ;

Scognamiglio, P ;

Boehme, R ;

Panebianco, R ;

Fiaccadori, F ;

Ferrari, C .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :968-975

[3]

CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333

[4] Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection [J].

Colonno, RJ ;

Genovesi, EV ;

Medina, I ;

Lamb, L ;

Durham, SK ;

Huang, ML ;

Corey, L ;

Littlejohn, M ;

Locarnini, S ;

Tennant, BC ;

Rose, B ;

Clark, JM .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1236-1245

[5] A new model of hepatitis B virus reinfection: Liver transplantation in the woodchuck [J].

Dahmen, U ;

Li, J ;

Dirsch, O ;

Fiedler, M ;

Lu, M ;

Roggendorf, M ;

Broelsch, CE .

TRANSPLANTATION, 2002, 74 (03) :373-380

[6] Adoptive transfer of immunity: A new strategy to interfere with severe hepatitis virus reinfection after woodchuck liver transplantation [J].

Dahmen, U ;

Dirsch, O ;

Li, J ;

Fiedle, M ;

Lu, M ;

Rispeter, K ;

Picucci, M ;

Broelsch, CE ;

Roggendorf, M .

TRANSPLANTATION, 2004, 77 (07) :965-972

[7]

Dikici B, 2003, PEDIATR INFECT DIS J, V22, P345

[8] Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection [J].

Foster, WK ;

Miller, DS ;

Marion, PL ;

Colonno, RJ ;

Kotlarski, I ;

Jilbert, AR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (08) :2624-2635

[9] Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection [J].

Genovesi, EV ;

Lamb, L ;

Medina, I ;

Taylor, D ;

Seifer, M ;

Innaimo, S ;

Colonno, RJ ;

Standring, DN ;

Clark, JM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (12) :3209-3217

[10]

GERLICH WH, 2004, HEPATITIS B VIRUS PR, P57

← 1 2 3 4 5 →